THE FOUNDATION FOR AIDS RESEARCH: Form 990, tax year 2009

View the entire original 990 at ProPublica ↗

Organization: THE FOUNDATION FOR AIDS RESEARCH (EIN 13-3163817)
Tax period: 2009-10-01 to 2010-09-30
Filed: 2011-06-01
IRS object ID: 201121529349300812
Schema version: 2009v1.7
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule I
Schedule J
Schedule M
Schedule O

Return header ReturnHeader

Field	Value	IRS element (for citing)
Timestamp	2011-06-01T13:19:20-04:00	Timestamp
Tax Period End Date	2010-09-30	TaxPeriodEndDate

Preparer Firm PreparerFirm

Preparer Firm Business Name PreparerFirmBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	GRANT THORNTON LLP	BusinessNameLine1

Preparer Firm US Address PreparerFirmUSAddress

Field	Value	IRS element (for citing)
Address Line1	666 THIRD AVENUE	AddressLine1
City	NEW YORK	City
State	NY	State
ZIP Code	100174011	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnType
Tax Period Begin Date	2009-10-01	TaxPeriodBeginDate

Filer Filer

Field	Value	IRS element (for citing)
EIN	133163817	EIN

Name Name

Field	Value	IRS element (for citing)
Business Name Line1	THE FOUNDATION FOR AIDS RESEARCH	BusinessNameLine1

Field	Value	IRS element (for citing)
Name Control	FOUN	NameControl
Phone	2128061600	Phone

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	120 wall street 13TH FLOOR	AddressLine1
City	NEW YORK	City
State	NY	State
ZIP Code	100053908	ZIPCode

Officer Officer

Field	Value	IRS element (for citing)
Name	BRADLEY JENSEN	Name
Title	ASST TREASURER, CFO	Title
Date Signed	2011-05-31	DateSigned
Authorize Third Party	true	AuthorizeThirdParty

Preparer Preparer

Field	Value	IRS element (for citing)
Phone	2125429609	Phone

Field	Value	IRS element (for citing)
Tax Year	2009	TaxYear
Build TS	2016-02-24 21:20:13Z	BuildTS

Form 990 IRS990

Doing Business As DoingBusinessAs

Field	Value	IRS element (for citing)
Business Name Line1	AMFAR AIDS RESEARCH FOUNDATION	BusinessNameLine1

Field	Value	IRS element (for citing)
Name Of Principal Officer Person	KEVIN FROST	NameOfPrincipalOfficerPerson

Address Principal Officer US AddressPrincipalOfficerUS

Field	Value	IRS element (for citing)
Address Line1	120 WALL STREET 13TH FLOOR	AddressLine1
City	new york	City
State	NY	State
ZIP Code	10005	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	35979190	GrossReceipts
Group Return For Affiliates	false	GroupReturnForAffiliates
Organization501c	X	Organization501c
Web Site	WWW.AMFAR.ORG	WebSite
Type Of Organization Corporation	X	TypeOfOrganizationCorporation
Year Formation	1983	YearFormation
State Legal Domicile	NY	StateLegalDomicile
Activity Or Mission Description	amfar is dedicated to ending the global aids epidemic through innovative research.	ActivityOrMissionDescription
Nbr Voting Members Governing Body	19	NbrVotingMembersGoverningBody
Nbr Independent Voting Members	19	NbrIndependentVotingMembers
Total Nbr Employees	96	TotalNbrEmployees
Total Nbr Volunteers	135	TotalNbrVolunteers
Total Gross UBI	0	TotalGrossUBI
Net Unrelated Business Txbl Income	0	NetUnrelatedBusinessTxblIncome
Contributions Grants Prior Year	20760601	ContributionsGrantsPriorYear
Contributions Grants Current Year	21965059	ContributionsGrantsCurrentYear
Program Service Revenue Prior Year	0	ProgramServiceRevenuePriorYear
Program Service Revenue CY	0	ProgramServiceRevenueCY
Investment Income Prior Year	-530822	InvestmentIncomePriorYear
Investment Income Current Year	506704	InvestmentIncomeCurrentYear
Other Revenue Prior Year	228155	OtherRevenuePriorYear
Other Revenue Current Year	2889638	OtherRevenueCurrentYear
Total Revenue Prior Year	20457934	TotalRevenuePriorYear
Total Revenue Current Year	25361401	TotalRevenueCurrentYear
Grants And Similar Amnts Prior Year	5230871	GrantsAndSimilarAmntsPriorYear
Grants And Similar Amnts CY	4604199	GrantsAndSimilarAmntsCY
Benefits Paid To Members Prior Year	0	BenefitsPaidToMembersPriorYear
Benefits Paid To Members CY	0	BenefitsPaidToMembersCY
Salaries Etc Prior Year	8171364	SalariesEtcPriorYear
Salaries Etc Current Year	7735764	SalariesEtcCurrentYear
Total Prof Fundrsng Exp Prior Year	492575	TotalProfFundrsngExpPriorYear
Total Prof Fundrsng Exp CY	483987	TotalProfFundrsngExpCY
Total Fundrsng Exp Current Year	4221300	TotalFundrsngExpCurrentYear
Other Expense Prior Year	10774953	OtherExpensePriorYear
Other Expenses Current Year	10930086	OtherExpensesCurrentYear
Total Expenses Prior Year	24669763	TotalExpensesPriorYear
Total Expenses Current Year	23754036	TotalExpensesCurrentYear
Revenues Less Expenses Prior Year	-4211829	RevenuesLessExpensesPriorYear
Revenues Less Expenses CY	1607365	RevenuesLessExpensesCY
Total Assets BOY	33507816	TotalAssetsBOY
Total Assets EOY	35804429	TotalAssetsEOY
Total Liabilities BOY	5274457	TotalLiabilitiesBOY
Total Liabilities EOY	5238663	TotalLiabilitiesEOY
Net Assets Or Fund Balances BOY	28233359	NetAssetsOrFundBalancesBOY
Net Assets Or Fund Balances EOY	30565766	NetAssetsOrFundBalancesEOY
Mission Description	The Foundation for AIDS Research is an international not-for profit organization incorporated in New York in 1989. amfAR was formed through the unification in 1985 of two not-for-profit organizations, the AIDS Medical Foundation ("AMF"), incorporated in New York in April 1983, and the National AIDS Research Foundation, incorporated in California in August 1985. First based in California, amfAR transferred its legal domicile to New York in 1989, using the initial incorporation documents of AMF, making it AMF's legal successor. amfAR has offices in New York, NY, Washington, D.C., and Bangkok, Thailand. On March 7, 2005, the board of trustees of the American Foundation for AIDS Research approved a change in legal name to "The Foundation for AIDS Research." On October 18, 2005, the New York State Department of State approved this change. In addition, the Foundation has secured approval for Doing Business As (DBA) the following: - American Foundation for AIDS Research - amfAR - AIDS Researc	MissionDescription
Significant New Program Services	false	SignificantNewProgramServices
Significant Change	false	SignificantChange
Expense	6336858	Expense
Grants	1716863	Grants
Revenue	0	Revenue
Description	RESEARCH: amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the National Institutes of Health. For further details, see Schedule o.	Description

Activity2 Activity2

Field	Value	IRS element (for citing)
Expense	5480583	Expense
Grants	2110078	Grants
Revenue	0	Revenue
Description	TREAT ASIA: amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) involves a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 23 adult and 20 pediatric sites throughout the region, which collaborate on a variety of projects. Eight papers based on the network's research were published in U.S. and international scientific journals in 2010. For further details, see Schedule o.	Description

Activity3 Activity3

Field	Value	IRS element (for citing)
Expense	2445829	Expense
Grants	0	Grants
Revenue	0	Revenue
Description	EDUCATION AND INFORMATION: amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to stimulate broad awareness of the need for better treatment and prevention methods. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policy makers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. For further details, see Schedule O.	Description

Activity Other ActivityOther (2 entries)

ExpenseExpense	GrantsGrants	RevenueRevenue	DescriptionDescription
1744743	657257	0	MSM Initiative
1569506	120000	0	public policy

Field	Value	IRS element (for citing)
Total Of Other Program Service Exp	3314249	TotalOfOtherProgramServiceExp
Total Of Other Program Service Grnt	777257	TotalOfOtherProgramServiceGrnt
Total Of Other Program Service Rev	0	TotalOfOtherProgramServiceRev
Total Program Service Expense	17577519	TotalProgramServiceExpense
Described In501 C3	true	DescribedIn501C3
Schedule B Required	true	ScheduleBRequired
Political Activities	false	PoliticalActivities
Lobbying Activities	true	LobbyingActivities
Donor Advised Funds	false	DonorAdvisedFunds
Conservation Easements	false	ConservationEasements
Collections Of Art	true	CollectionsOfArt
Credit Counseling	false	CreditCounseling
Term Or Permanent Endowments	true	TermOrPermanentEndowments
Balance Sheet Amounts Reported	true	BalanceSheetAmountsReported
Independent Audit Financial Stmt	true	IndependentAuditFinancialStmt
Consolidated Audit Financial Stmt	false	ConsolidatedAuditFinancialStmt
School	false	School
Foreign Office	true	ForeignOffice
Foreign Activities	true	ForeignActivities
More Than5000 K To Organizations	true	MoreThan5000KToOrganizations
More Than5000 K To Individuals	false	MoreThan5000KToIndividuals
Professional Fundraising	true	ProfessionalFundraising
Fundraising Activities	true	FundraisingActivities
Gaming	false	Gaming
Hospital	false	Hospital
Grants To Organizations	true	GrantsToOrganizations
Grants To Individuals	false	GrantsToIndividuals
Schedule J Required	true	ScheduleJRequired
Tax Exempt Bonds	false	TaxExemptBonds
Excess Benefit Transaction	false	ExcessBenefitTransaction
Prior Excess Benefit Transaction	false	PriorExcessBenefitTransaction
Loan To Officer Or DQP	false	LoanToOfficerOrDQP
Grant To Related Person	false	GrantToRelatedPerson
Bsnss Rltnshp With Organization	false	BsnssRltnshpWithOrganization
Bsnss Rltnshp Thru Family Member	false	BsnssRltnshpThruFamilyMember
Officer Entity With Bsnss Rltnshp	false	OfficerEntityWithBsnssRltnshp
Deductible Non Cash Contributions	true	DeductibleNonCashContributions
Deductible Contributions Of Art	false	DeductibleContributionsOfArt
Terminated	false	Terminated
Partial Liquidation	false	PartialLiquidation
Disregarded Entity	false	DisregardedEntity
Related Entity	false	RelatedEntity
Related Org Controlled Entity	false	RelatedOrgControlledEntity
Transfers To Exempt Non Chrtbl Org	false	TransfersToExemptNonChrtblOrg
Activities Conducted Partnership	false	ActivitiesConductedPartnership
Schedule O Required	true	ScheduleORequired
Number Forms Transmitted With1096	77	NumberFormsTransmittedWith1096
Number W2 G Included	0	NumberW2GIncluded
Compliance With Backup Witholding	true	ComplianceWithBackupWitholding
Number Of Employees	96	NumberOfEmployees
Employment Tax Returns Filed	true	EmploymentTaxReturnsFiled
Unrelated Business Income	false	UnrelatedBusinessIncome
Foreign Financial Account	true	ForeignFinancialAccount
Name Of Foreign Country	TH	NameOfForeignCountry
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTrans
Taxable Party Notification	false	TaxablePartyNotification
Non Deductible Contributions	false	NonDeductibleContributions
Quid Pro Quo Contributions	false	QuidProQuoContributions
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOf
Funds To Pay Premiums	false	FundsToPayPremiums
Premiums Paid	false	PremiumsPaid
Nbr Voting Governing Body Members	19	NbrVotingGoverningBodyMembers
Number Independent Voting Members	19	NumberIndependentVotingMembers
Family Or Business Relationship	false	FamilyOrBusinessRelationship
Delegation Of Management Duties	false	DelegationOfManagementDuties
Changes To Organizing Docs	false	ChangesToOrganizingDocs
Material Diversion Or Misuse	false	MaterialDiversionOrMisuse
Members Or Stockholders	false	MembersOrStockholders
Election Of Board Members	false	ElectionOfBoardMembers
Decisions Subject To Approval	false	DecisionsSubjectToApproval
Minutes Of Governing Body	true	MinutesOfGoverningBody
Minutes Of Committees	true	MinutesOfCommittees
Officer Mailing Address	false	OfficerMailingAddress
Local Chapters	false	LocalChapters
Form990 Provided To Governing Body	true	Form990ProvidedToGoverningBody
Conflict Of Interest Policy	true	ConflictOfInterestPolicy
Annual Disclosure Covered Persons	true	AnnualDisclosureCoveredPersons
Regular Monitoring Enforcement	true	RegularMonitoringEnforcement
Whistleblower Policy	true	WhistleblowerPolicy
Document Retention Policy	true	DocumentRetentionPolicy
Compensation Process CEO	true	CompensationProcessCEO
Compensation Process Other	true	CompensationProcessOther
Investment In Joint Venture	false	InvestmentInJointVenture
States Where Copy Of Return Is Filed	AL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AZ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	AR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CO	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	CT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	FL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	GA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	HI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	IL	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	KY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	LA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ME	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MD	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	MS	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NJ	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NM	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NY	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	NC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	ND	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OH	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OK	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	OR	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	PA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	RI	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	SC	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	TN	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	UT	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	VA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WA	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WV	StatesWhereCopyOfReturnIsFiled
States Where Copy Of Return Is Filed	WI	StatesWhereCopyOfReturnIsFiled
Own Website	X	OwnWebsite
Upon Request	X	UponRequest

The Books Are In Care Of TheBooksAreInCareOf

Field	Value	IRS element (for citing)
Name Person	BRADLEY JENSEN	NamePerson
Telephone Number	2128061703	TelephoneNumber

Address US AddressUS

Field	Value	IRS element (for citing)
Address Line1	120 WALL STREET 13TH FLOOR	AddressLine1
City	new york	City
State	NY	State
ZIP Code	100053908	ZIPCode

Form990 Part VII Section A Form990PartVIISectionA (39 entries)

TitleTitle	Average Hours Per WeekAverageHoursPerWeek	Individual Trustee Or DirectorIndividualTrusteeOrDirector	Reportable Comp From OrganizationReportableCompFromOrganization	Reportable Comp From Related OrgsReportableCompFromRelatedOrgs	Other CompensationOtherCompensation	OfficerOfficer	Key EmployeeKeyEmployee	Highest Compensated EmployeeHighestCompensatedEmployee	FormerFormer
Dame Elizabeth Taylor
Founding Intl Chairman	1.0	X	0	0	0
Mathilde Krim PhD
Founding Chairman	1.0	X	0	0	0
Kenneth Cole
Chairman of the Board	1.0	X	0	0	0	X
Patricia J Matson
co-Chairman	1.0	X	0	0	0	X
John C Simons
Vice Chairman	1.0	X	0	0	0
Wallace Sheft CPA
Treasurer	1.0	X	0	0	0	X
DIANE L TAYLOR
secretary	1.0	X	0	0	0	X
Arlen H Andelson
Trustee	1.0	X	0	0	0
Harry Belafonte
Trustee (Non-voting)	1.0	X	0	0	0
David Bohnett
Trustee	1.0	X	0	0	0
Zev Braun
Trustee (non-voting)	1.0	X	0	0	0
Jonathan S Canno
Trustee	1.0	X	0	0	0
Donald Capoccia
Trustee (non-voting)	1.0	X	0	0	0
R Martin Chavez PhD
Trustee	1.0	X	0	0	0
Jane B Eisner
Trustee	1.0	X	0	0	0
Michael J Klingensmith
Trustee	1.0	X	0	0	0
Michele V McNeill PharmD
Trustee (non-voting)	1.0	X	0	0	0
Richard H Metzner
Trustee	1.0	X	0	0	0
Edward Milstein
Trustee	1.0	X	0	0	0
CINDY RACHOFSKY
Trustee	1.0	X	0	0	0
Vincent A Roberti
Trustee	1.0	X	0	0	0
Alan D Schwartz
Trustee (non-voting)	1.0	X	0	0	0
Kevin Wendle
Trustee (NON-voting)	1.0	X	0	0	0
regan hoffman
trustee	1.0	X	0	0	0
MERVYN F SILVERMAN MDMPH
trustee	1.0	X	0	0	0
Kevin Frost
Chief Executive Officer	40.0		294100	0	32217	X
John F Logan JD PhD
Asst Secretary, Vice President	40.0		179424	0	20308	X
Rowena Johnston
Asst Secretary, Vice President	40.0		138712	0	17571	X
Bradley Jensen
Asst Treasurer, CFO	40.0		192220	0	34529	X
edward donnelly
asst treasurer, controller	40.0		118397	0	15917	X
annette sohn
Vice President, treat asia	40.0		161626	0	12430		X
Eric Muscatell
Director, Philanthropy	40.0		140535	0	18238			X
Andrew McInness
Director, Publications	40.0		123398	0	32215			X
gregory borroff
vice president of development	40.0		138354	0	6955			X
michael cowing
senior advisor for programs	40.0		122269	0	16403			X
anthony ancona
vice president, human resource	40.0		131683	0	6893			X
joshua lamont
Vice President, Public Info	40.0		174397	0	7262				X
Jerome J Radwin
Vice Chairman	40.0		300000	0	0				X
Jeff Smith
Director, TREAT Asia	40.0		119330	0	8122				X

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	2334445	TotalReportableCompFromOrg
Total Reportable Comp Frm Rltd Orgs	0	TotalReportableCompFrmRltdOrgs
Total Other Compensation	229060	TotalOtherCompensation
Number Individuals GT100 K	16	NumberIndividualsGT100K
Formers Listed	true	FormersListed
Total Comp GT150 K	true	TotalCompGT150K
Compensation From Other Sources	false	CompensationFromOtherSources

Contractor Compensation ContractorCompensation (5 entries)

Address Line1AddressOfContractor/AddressUS/AddressLine1	CityAddressOfContractor/AddressUS/City	StateAddressOfContractor/AddressUS/State	ZIP CodeAddressOfContractor/AddressUS/ZIPCode	Description Of ServicesDescriptionOfServices	CompensationCompensation
aab production
32 west 25th street suite 300	NEW YORK	NY	10011	event production	322200
grant thornton llp
1901 w meyers road suite 455	OAKBROOK TERRACE	IL	60181	accounting & audit	152788
downey mcgrath group inc
27 west 24th street suite 900	NEW YORK	NY	10010	program tech support	150000
Global Health Strategies
27 W 27TH STREET SUITE 900	NEW YORK	NY	10010	scientific consult	135000
Global Health Institute
3403 rolling court	CHEVY CHASE	MD	20815	consulting	120000

Field	Value	IRS element (for citing)
Number Of Contractors GT100 K	7	NumberOfContractorsGT100K
Federated Campaigns	445702	FederatedCampaigns
Fundraising Events	7838799	FundraisingEvents
Government Grants	5959900	GovernmentGrants
All Other Contributions	7720658	AllOtherContributions
Noncash Contributions	5373	NoncashContributions
Total Contributions	21965059	TotalContributions
Total Program Service Revenue	0	TotalProgramServiceRevenue

Investment Income InvestmentIncome

Field	Value	IRS element (for citing)
Total Revenue Column	516589	TotalRevenueColumn
Exclusion	$516,589	ExclusionAmount

Income From Invest Bond Proceeds IncomeFromInvestBondProceeds

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn

Royalties Revenue RoyaltiesRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	150248	TotalRevenueColumn
Exclusion	$150,248	ExclusionAmount

Gross Amount Sales Assets GrossAmountSalesAssets

Field	Value	IRS element (for citing)
Securities	4604120	Securities

Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses

Field	Value	IRS element (for citing)
Securities	4614005	Securities

Gain Or Loss GainOrLoss

Field	Value	IRS element (for citing)
Securities	-9885	Securities

Net Gain Or Loss Investments NetGainOrLossInvestments

Field	Value	IRS element (for citing)
Total Revenue Column	-9885	TotalRevenueColumn
Exclusion	-$9,885	ExclusionAmount

Field	Value	IRS element (for citing)
Gross Income Fundraising Events	8276910	GrossIncomeFundraisingEvents
Cntrbtns Rprtd Fundraising Events	7838799	CntrbtnsRprtdFundraisingEvents
Fundraising Direct Expenses	5987021	FundraisingDirectExpenses

Net Income From Fundraising Events NetIncomeFromFundraisingEvents

Field	Value	IRS element (for citing)
Total Revenue Column	2289889	TotalRevenueColumn
Exclusion	$2,289,889	ExclusionAmount

Net Income From Gaming NetIncomeFromGaming

Field	Value	IRS element (for citing)
Total Revenue Column	0	TotalRevenueColumn

Field	Value	IRS element (for citing)
Gross Sales Of Inventory	438392	GrossSalesOfInventory
Cost Of Goods Sold	16763	CostOfGoodsSold

Net Income Or Loss NetIncomeOrLoss

Field	Value	IRS element (for citing)
Total Revenue Column	421630	TotalRevenueColumn
Exclusion	$421,630	ExclusionAmount

Other Revenue Misc OtherRevenueMisc (2 entries)

DescriptionDescription	Business CodeBusinessCode	Total Revenue ColumnTotalRevenueColumn	ExclusionExclusionAmount
LIST RENTALS	900099	27804	$27,804
MISCELLANEOUS INCOME	900099	67	$67

Field	Value	IRS element (for citing)
Total Other Revenue	27871	TotalOtherRevenue

Total Revenue TotalRevenue

Field	Value	IRS element (for citing)
Total Revenue Column	25361401	TotalRevenueColumn
Exclusion	$3,396,342	ExclusionAmount

Grants To Domestic Orgs GrantsToDomesticOrgs

Field	Value	IRS element (for citing)
Total	1522428	Total
Program Services	1522428	ProgramServices

Grants To Domestic Individuals GrantsToDomesticIndividuals

Field	Value	IRS element (for citing)
Total	0	Total

Foreign Grants ForeignGrants

Field	Value	IRS element (for citing)
Total	3081771	Total
Program Services	3081771	ProgramServices

Benefits To Members BenefitsToMembers

Field	Value	IRS element (for citing)
Total	0	Total

Comp Current Officers Directors CompCurrentOfficersDirectors

Field	Value	IRS element (for citing)
Total	2030119	Total
Program Services	1269296	ProgramServices
Management And General	448317	ManagementAndGeneral
Fundraising	312506	Fundraising

Comp Disqual Persons CompDisqualPersons

Field	Value	IRS element (for citing)
Total	0	Total

Other Salaries And Wages OtherSalariesAndWages

Field	Value	IRS element (for citing)
Total	4275896	Total
Program Services	2925002	ProgramServices
Management And General	309822	ManagementAndGeneral
Fundraising	1041072	Fundraising

Pension Plan Contributions PensionPlanContributions

Field	Value	IRS element (for citing)
Total	245872	Total
Program Services	163242	ProgramServices
Management And General	20112	ManagementAndGeneral
Fundraising	62518	Fundraising

Other Employee Benefits OtherEmployeeBenefits

Field	Value	IRS element (for citing)
Total	745819	Total
Program Services	534066	ProgramServices
Management And General	89478	ManagementAndGeneral
Fundraising	122275	Fundraising

Payroll Taxes PayrollTaxes

Field	Value	IRS element (for citing)
Total	438058	Total
Program Services	281980	ProgramServices
Management And General	53654	ManagementAndGeneral
Fundraising	102424	Fundraising

Fees For Services Management FeesForServicesManagement

Field	Value	IRS element (for citing)
Total	0	Total

Fees For Services Legal FeesForServicesLegal

Field	Value	IRS element (for citing)
Total	98505	Total
Program Services	91169	ProgramServices
Management And General	3729	ManagementAndGeneral
Fundraising	3607	Fundraising

Fees For Services Accounting FeesForServicesAccounting

Field	Value	IRS element (for citing)
Total	164947	Total
Management And General	164947	ManagementAndGeneral

Fees For Services Lobbying FeesForServicesLobbying

Field	Value	IRS element (for citing)
Total	120602	Total
Program Services	120602	ProgramServices

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	483987	Total
Fundraising	483987	Fundraising

Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees

Field	Value	IRS element (for citing)
Total	62734	Total
Management And General	62734	ManagementAndGeneral

Fees For Services Other FeesForServicesOther

Field	Value	IRS element (for citing)
Total	1023998	Total
Program Services	663820	ProgramServices
Management And General	92709	ManagementAndGeneral
Fundraising	267469	Fundraising

Advertising Advertising

Field	Value	IRS element (for citing)
Total	90427	Total
Program Services	86960	ProgramServices
Management And General	373	ManagementAndGeneral
Fundraising	3094	Fundraising

Office Expenses OfficeExpenses

Field	Value	IRS element (for citing)
Total	67603	Total
Program Services	40263	ProgramServices
Management And General	8108	ManagementAndGeneral
Fundraising	19232	Fundraising

Information Technology InformationTechnology

Field	Value	IRS element (for citing)
Total	0	Total

Royalties Royalties

Field	Value	IRS element (for citing)
Total	0	Total

Occupancy Occupancy

Field	Value	IRS element (for citing)
Total	1157448	Total
Program Services	782157	ProgramServices
Management And General	175145	ManagementAndGeneral
Fundraising	200146	Fundraising

Travel Travel

Field	Value	IRS element (for citing)
Total	766208	Total
Program Services	501385	ProgramServices
Management And General	7886	ManagementAndGeneral
Fundraising	256937	Fundraising

Travel Entrtnmnt Public Officials TravelEntrtnmntPublicOfficials

Field	Value	IRS element (for citing)
Total	0	Total

Conferences Meetings ConferencesMeetings

Field	Value	IRS element (for citing)
Total	840351	Total
Program Services	749606	ProgramServices
Management And General	7870	ManagementAndGeneral
Fundraising	82875	Fundraising

Interest Interest

Field	Value	IRS element (for citing)
Total	0	Total

Payments To Affiliates PaymentsToAffiliates

Field	Value	IRS element (for citing)
Total	0	Total

Depreciation Depletion DepreciationDepletion

Field	Value	IRS element (for citing)
Total	251647	Total
Program Services	170299	ProgramServices
Management And General	38134	ManagementAndGeneral
Fundraising	43214	Fundraising

Insurance Insurance

Field	Value	IRS element (for citing)
Total	163288	Total
Program Services	110343	ProgramServices
Management And General	24709	ManagementAndGeneral
Fundraising	28236	Fundraising

Other Expenses OtherExpenses (5 entries)

DescriptionDescription	TotalTotal	Program ServicesProgramServices	Management And GeneralManagementAndGeneral	FundraisingFundraising
PROGRAM MATERIALS	2285977	2285977	0	0
BAD DEBT EXPENSE	1280142	865069	193711	221362
POSTAGE & SHIPPING	687829	285635	3356	398838
PRINTING	553508	193674	0	359834
PROGRAM TECHNICAL SUPPORT	471530	471530	0	0

All Other Expenses AllOtherExpenses

Field	Value	IRS element (for citing)
Total	843342	Total
Program Services	381245	ProgramServices
Management And General	250423	ManagementAndGeneral
Fundraising	211674	Fundraising

Total Functional Expenses TotalFunctionalExpenses

Field	Value	IRS element (for citing)
Total	23754036	Total
Program Services	17577519	ProgramServices
Management And General	1955217	ManagementAndGeneral
Fundraising	4221300	Fundraising

Field	Value	IRS element (for citing)
Joint Costs	X	JointCosts

Total Joint Costs TotalJointCosts

Field	Value	IRS element (for citing)
Total	1019556	Total
Program Services	374578	ProgramServices
Management And General	0	ManagementAndGeneral
Fundraising	644978	Fundraising

Cash Non Interest Bearing CashNonInterestBearing

Field	Value	IRS element (for citing)
BOY	861762	BOY
EOY	5446802	EOY

Savings And Temp Cash Investments SavingsAndTempCashInvestments

Field	Value	IRS element (for citing)
BOY	9541547	BOY
EOY	5963522	EOY

Pledges And Grants Receivable PledgesAndGrantsReceivable

Field	Value	IRS element (for citing)
BOY	6732230	BOY
EOY	5825604	EOY

Accounts Receivable AccountsReceivable

Field	Value	IRS element (for citing)
BOY	1620968	BOY
EOY	2471863	EOY

Inventories For Sale Or Use InventoriesForSaleOrUse

Field	Value	IRS element (for citing)
BOY	94415	BOY
EOY	144295	EOY

Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges

Field	Value	IRS element (for citing)
BOY	376156	BOY
EOY	556359	EOY

Field	Value	IRS element (for citing)
Land Buildings Equipment Basis	2977785	LandBuildingsEquipmentBasis
Land Bldg Equipment Accum Deprec	2506228	LandBldgEquipmentAccumDeprec

Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet

Field	Value	IRS element (for citing)
BOY	636526	BOY
EOY	471557	EOY

Investments Pub Traded Securities InvestmentsPubTradedSecurities

Field	Value	IRS element (for citing)
BOY	12420043	BOY
EOY	13623286	EOY

Other Assets Total OtherAssetsTotal

Field	Value	IRS element (for citing)
BOY	1224169	BOY
EOY	1301141	EOY

Total Assets TotalAssets

Field	Value	IRS element (for citing)
BOY	33507816	BOY
EOY	35804429	EOY

Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses

Field	Value	IRS element (for citing)
BOY	1712165	BOY
EOY	1644227	EOY

Grants Payable GrantsPayable

Field	Value	IRS element (for citing)
BOY	1255912	BOY
EOY	573764	EOY

Deferred Revenue DeferredRevenue

Field	Value	IRS element (for citing)
BOY	1877071	BOY
EOY	2679898	EOY

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
BOY	429309	BOY
EOY	340774	EOY

Total Liabilities TotalLiabilities

Field	Value	IRS element (for citing)
BOY	5274457	BOY
EOY	5238663	EOY

Field	Value	IRS element (for citing)
Follow SFAS117	X	FollowSFAS117

Unrestricted Net Assets UnrestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	15502757	BOY
EOY	18926218	EOY

Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	12411691	BOY
EOY	11312379	EOY

Permanently Restricted Net Assets PermanentlyRestrictedNetAssets

Field	Value	IRS element (for citing)
BOY	318911	BOY
EOY	327169	EOY

Total Net Assets Fund Balances TotalNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	28233359	BOY
EOY	30565766	EOY

Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances

Field	Value	IRS element (for citing)
BOY	33507816	BOY
EOY	35804429	EOY

Field	Value	IRS element (for citing)
Method Of Accounting Accrual	X	MethodOfAccountingAccrual
Accountant Compile Or Review	false	AccountantCompileOrReview
FS Audited	true	FSAudited
Audit Committee	true	AuditCommittee
Financial Statement Separate	X	FinancialStatementSeparate
Federal Grant Audit Required	true	FederalGrantAuditRequired
Federal Grant Audit Performed	true	FederalGrantAuditPerformed

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org170b1 Avi	X	PubliclySupportedOrg170b1Avi

Gifts Grants Contrib Received170 GiftsGrantsContribReceived170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	18200457	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	22038265	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	30491706	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	20760601	CurrentTaxYearMinus1Year
Current Tax Year	22553697	CurrentTaxYear
Total	114044726	Total

Total170 Total170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	18200457	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	22038265	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	30491706	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	20760601	CurrentTaxYearMinus1Year
Current Tax Year	22553697	CurrentTaxYear
Total	114044726	Total

Field	Value	IRS element (for citing)
Amounts Subst Contributors Total	7908448	AmountsSubstContributorsTotal
Public Support Total170	106136278	PublicSupportTotal170

Gross Investment Income170 GrossInvestmentIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	670429	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	822092	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	842799	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	643473	CurrentTaxYearMinus1Year
Current Tax Year	668573	CurrentTaxYear
Total	3647366	Total

Other Income170 OtherIncome170

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	21009	CurrentTaxYearMinus4Years
Current Tax Year Minus3 Years	38835	CurrentTaxYearMinus3Years
Current Tax Year Minus2 Years	4819221	CurrentTaxYearMinus2Years
Current Tax Year Minus1 Year	117005	CurrentTaxYearMinus1Year
Current Tax Year	2317760	CurrentTaxYear
Total	7313830	Total

Field	Value	IRS element (for citing)
Total Support	125005922	TotalSupport
Gross Receipts From Admissions Etc	1052722	GrossReceiptsFromAdmissionsEtc
Public Support Pertcentage170	0.84905	PublicSupportPertcentage170
Public Support Pertcent Prior Year	0.87094	PublicSupportPertcentPriorYear
Thirty Three Percnt Tests CY170	X	ThirtyThreePercntTestsCY170

Schedule B IRS990ScheduleB

Contributor Info ContributorInfo

Field	Value	IRS element (for citing)
Contributor Number	RESTRICTED	ContributorNumber

Contributor Name Business ContributorNameBusiness

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor Address US ContributorAddressUS

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Aggregate Contributions	RESTRICTED	AggregateContributions

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Total Grassroots Lobbying		TotalGrassrootsLobbying
Total Direct Lobbying		TotalDirectLobbying
Total Lobbying Expenditures		TotalLobbyingExpenditures
Other Exempt Purpose Expenditures		OtherExemptPurposeExpenditures
Total Exempt Purpose Expenditures		TotalExemptPurposeExpenditures
Lobbying Nontaxable		LobbyingNontaxableAmount
Grassroots Nontaxable		GrassrootsNontaxableAmount
Tot Lobbying Grassroot Minus Non Tx		TotLobbyingGrassrootMinusNonTx
Tot Lobby Expend Mns Lobbying Nontx		TotLobbyExpendMnsLobbyingNontx
Volunteers	false	Volunteers
Paid Staff Or Management	true	PaidStaffOrManagement
Media Advertisements	false	MediaAdvertisements
Mailings Members	false	MailingsMembers
Publications Or Broadcast	false	PublicationsOrBroadcast
Grants Other Organizations	false	GrantsOtherOrganizations
Direct Contact Legislators	true	DirectContactLegislators
Direct Contact Legislators	$211,592	DirectContactLegislatorsAmount
Rallies Demonstrations	false	RalliesDemonstrations
Other Activities	false	OtherActivities
Total Lobbying Expenditures IIB	211592	TotalLobbyingExpendituresIIB
Not Described In501c3	false	NotDescribedIn501c3
Form4720 Filed4912 Tax	false	Form4720Filed4912Tax

Form990 Schedule C Part IV Form990ScheduleCPartIV

Field	Value	IRS element (for citing)
Identifier	Lobbying Expenses	Identifier
Return Reference	Part II-B	ReturnReference
Explanation	(1B) VP FOR POLICY AND DEPUTY BOTH SPENT STAFF TIME ON LEGISLATIVE ADVOCACY. THE AMOUNT OF EXPENDITURES RELATED TO THIS LINE ITEM TOTALS $11,413 (AND IS INCLUDED IN THE $211,592 REPORTED ON LINE 1(G)). (1G) WE DEVELOPED ISSUE BRIEFS ON THE GLOBAL AIDS RESPONSE, YOUTH AND HIV, AND US GOVERNMENT INVESTMENTS IN AIDS AND HEALTH GENERALLY. THESE ISSUE BRIEFS ARE SENT TO CAPITOL HILL OFFICES; WE MEET REGULARLY WITH STAFF TO MEMBERS OF CONGRESS AND THE ADMINISTRATION. WE HELD BRIEFINGS ON CAPITOL HILL ON HIV AND YOUTH, AS WELL AS AIDS RESEARCH. WE ALSO HELD A FORUM ON GLOBAL MSM/HIV ISSUES IN WASHINGTON, DC. AMFAR USES THE BRIEFINGS AS AN EDUCATIONAL TOOL.	Explanation

Schedule D IRS990ScheduleD

Art Public Exhibition Amts ArtPublicExhibitionAmts

Field	Value	IRS element (for citing)
Assets In Part X	144295	AssetsInPartX

Field	Value	IRS element (for citing)
Held Works Of Art Amts		HeldWorksOfArtAmts

Collection Used For Other CollectionUsedForOther

Field	Value	IRS element (for citing)
Collection Used For Other Purposes	X	CollectionUsedForOtherPurposes
Description Of Other Purposes	Donated Items, Inventory etc.	DescriptionOfOtherPurposes

Field	Value	IRS element (for citing)
Solicited Assets For Sale	true	SolicitedAssetsForSale

Current Year CurrentYear

Field	Value	IRS element (for citing)
Beginning Of Year Balance	516826	BeginningOfYearBalance
Contributions	8258	Contributions
Investment Earnings Or Losses	35999	InvestmentEarningsOrLosses
End Of Year Balance	561083	EndOfYearBalance

Current Year Minus1 Year CurrentYearMinus1Year

Field	Value	IRS element (for citing)
Beginning Of Year Balance	470065	BeginningOfYearBalance
Contributions	9378	Contributions
Investment Earnings Or Losses	37383	InvestmentEarningsOrLosses
End Of Year Balance	516826	EndOfYearBalance

Field	Value	IRS element (for citing)
Permanent Endowment EOY Balance	0.64670	PermanentEndowmentEOYBalance
Term Endowment EOY Balance	0.35330	TermEndowmentEOYBalance
Endowments Held By Unrelated Orgs	false	EndowmentsHeldByUnrelatedOrgs
Endowments Held By Related Orgs	false	EndowmentsHeldByRelatedOrgs
Land		Land
Buildings		Buildings

Leasehold Improvements LeaseholdImprovements

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	781297	OtherCostOrOtherBasis
Depreciation	309740	Depreciation
Book Value	471557	BookValue

Equipment Equipment

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	234641	OtherCostOrOtherBasis
Depreciation	234641	Depreciation
Book Value	0	BookValue

Other Land Buildings OtherLandBuildings

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	1961847	OtherCostOrOtherBasis
Depreciation	1961847	Depreciation
Book Value	0	BookValue

Field	Value	IRS element (for citing)
Total Of Book Value Land Buildings	471557	TotalOfBookValueLandBuildings
Federal Income Tax Liability	0	FederalIncomeTaxLiability

Other Liabilities OtherLiabilities

Field	Value	IRS element (for citing)
Description	MISCELLANEOUS	Description
Amount	$340,774	Amount

Field	Value	IRS element (for citing)
Total Of Amounts	340774	TotalOfAmounts
Total Revenue	25361401	TotalRevenue
Total Expenses	23754036	TotalExpenses
Excess Or Deficit For Year	1607365	ExcessOrDeficitForYear
Net Unrealized GL On Investments	481762	NetUnrealizedGLOnInvestments
Other	$243,280	OtherAmount
Total Adjustments	725042	TotalAdjustments
Excess Or Deficit Per FS	2332407	ExcessOrDeficitPerFS
Tot Revenue Etc Audited Fincl Stmt	26244056	TotRevenueEtcAuditedFinclStmt
Net Unrealized Gains Investments	481762	NetUnrealizedGainsInvestments
Donated Srvc And Use Of Facilities	157613	DonatedSrvcAndUseOfFacilities
Other Revenues	243280	OtherRevenues
Revenue Not Rptd F990	882655	RevenueNotRptdF990
Revenue Subtotal	25361401	RevenueSubtotal
Total Revenue Per Form990	25361401	TotalRevenuePerForm990
Tot Expenses Etc Audited Fincl Stmt	23911649	TotExpensesEtcAuditedFinclStmt
Donated Services Use Of Facilities	157613	DonatedServicesUseOfFacilities
Expenses Not Rptd F990	157613	ExpensesNotRptdF990
Expenses Subtotal	23754036	ExpensesSubtotal
Total Expenses Per Form990	23754036	TotalExpensesPerForm990

Form990 Schedule D Part XIV Form990ScheduleDPartXIV (4 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
Endowments	Part V, Line 4	AMFAR's endowment fund is intended to fund the various general research programs the organization sponsors. Schedule D, Part III, Line 4 AMFAR holds various items of jewelry, photographs and other items of artistic value that have been donated to the organization for sale at special events. The organization has maintained these items in inventory for a few years and is in the process of selling them.
Reclassifications		In September 2010, New York State passed its own version of UPMIFA ("NYPMIFA") that applies to amfar's fiscal 2010 financial statements. Accordingly, certain amounts in the 2009 financial statements and footnote disclosures with respect to the organization's endowment have been reclassified to conform with the 2010 financial statement presentation. AMFAR has adjusted its Schedule d, Part V endowment disclosure to conform to the audited financial statement presentation. Certain amounts in the 2009 financial statements and footnote disclosures have been reclassified to conform with the 2010 financial statement presentation.
FIN 48		amfAR adopted new guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and guidance on measurement, classification, interest and penalties, and disclosure. This standard had no material impact on the accompanying financial statements. The tax years ended 2007, 2008, and 2009 are still open to audit for both federal and state purposes. amfAR has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions.
reconciliation		part XI, Line 8 change in value of beneficial interest in third party trust: $243,280 part XII, Line 2d change in value of beneficial interest in third party trust: $243,280

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	true	GrantRecordsMaintained

Accts Actvs Out US Table AcctsActvsOutUSTable (11 entries)

RegionRegion	Number Of OfficesNumberOfOffices	Number Of EmployeesNumberOfEmployees	Type Of Activities ConductedTypeOfActivitiesConducted	Specific Services ProvidedSpecificServicesProvided	Total ExpendituresTotalExpenditures
Central America and the Caribbean	0	0	Grantmaking	N/A	105000
Russia and the Newly Independent States	0	0	Grantmaking	N/A	114560
East Asia and the Pacific	1	20	Grantmaking	N/A	2621149
North America	0	0	Fundraising	N/A	114339
East Asia and the Pacific	1	20	Program Services	Therapeutics Research	1692080
Europe (Including Iceland and Greenland)	0	0	Grantmaking	N/A	363851
Europe (Including Iceland and Greenland)	0	0	Fundraising	N/A	2584923
Middle East and North Africa	0	0	Fundraising	N/A	639651
South America	0	0	Grantmaking	N/A	143409
South Asia	0	0	Grantmaking	N/A	56662
Sub-Saharan Africa	0	0	Grantmaking	N/A	171681

Field	Value	IRS element (for citing)
Total Number Of Offices	2	TotalNumberOfOffices
Total Number Of Employees	40	TotalNumberOfEmployees
Total Amount Spent	8607305	TotalAmountSpent

Grants To Orgs Outside US GrantsToOrgsOutsideUS (131 entries)

RegionRegion	Purpose Of GrantPurposeOfGrant	Amount Of Cash GrantAmountOfCashGrant	Manner Of Cash DisbursementMannerOfCashDisbursement
Caribbean/Central Americ	MSM Initiative	15000	wire transfe
Caribbean/Central Americ	MSM Initiative	30000	wire transfe
Caribbean/Central Americ	MSM Initiative	15000	wire transfe
Caribbean/Central Americ	MSM Initiative	15000	wire transfe
Caribbean/Central Americ	MSM Initiative	15000	wire transfe
Caribbean/Central Americ	MSM Initiative	15000	wire transfe
East Asia/Pacific	Social/Behavioral Research	15702	wire transfe
East Asia/Pacific	MSM Initiative	15000	wire transfe
East Asia/Pacific	MSM Initiative	29998	wire transfe
East Asia/Pacific	MSM Initiative	15000	wire transfe
East Asia/Pacific	MSM Initiative	15000	wire transfe
East Asia/Pacific	MSM Initiative	14975	wire transfe
East Asia/Pacific	MSM Initiative	29728	wire transfe
East Asia/Pacific	MSM Initiative	15000	wire transfe
East Asia/Pacific	MSM Initiative	15980	wire transfe
East Asia/Pacific	TREAT Asia	13700	wire transfe
East Asia/Pacific	TREAT Asia	16500	wire transfe
East Asia/Pacific	TREAT Asia	16500	wire transfe
East Asia/Pacific	TREAT Asia	16500	wire transfe
East Asia/Pacific	TREAT Asia	16500	wire transfe
East Asia/Pacific	TREAT Asia	16500	wire transfe
East Asia/Pacific	TREAT Asia	20500	wire transfe
East Asia/Pacific	TREAT Asia	16500	wire transfe
East Asia/Pacific	TREAT Asia	7500	wire transfe
East Asia/Pacific	TREAT Asia	7500	wire transfe
East Asia/Pacific	TREAT Asia	6975	wire transfe
East Asia/Pacific	TREAT Asia	7350	wire transfe
East Asia/Pacific	TREAT Asia	7500	wire transfe
East Asia/Pacific	TREAT Asia	6075	wire transfe
East Asia/Pacific	TREAT Asia	7500	wire transfe
East Asia/Pacific	TREAT Asia	7500	wire transfe
East Asia/Pacific	TREAT Asia	6000	wire transfe
East Asia/Pacific	TREAT Asia	7500	wire transfe
East Asia/Pacific	TREAT Asia	14543	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	14950	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	14018	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	15000	wire transfe
East Asia/Pacific	TREAT Asia	14999	wire transfe
East Asia/Pacific	TREAT Asia	5625	wire transfe
East Asia/Pacific	TREAT Asia	5625	wire transfe
East Asia/Pacific	TREAT Asia	5625	wire transfe
East Asia/Pacific	TREAT Asia	5625	wire transfe
East Asia/Pacific	TREAT Asia	14999	wire transfe
East Asia/Pacific	TREAT Asia	14999	wire transfe
East Asia/Pacific	TREAT Asia	11250	wire transfe
East Asia/Pacific	TREAT Asia	11250	wire transfe
East Asia/Pacific	TREAT Asia	11250	wire transfe
East Asia/Pacific	TREAT Asia	34875	wire transfe
East Asia/Pacific	TREAT Asia	277990	wire transfe
East Asia/Pacific	TREAT Asia	119666	wire transfe
East Asia/Pacific	TREAT Asia	187285	wire transfe
East Asia/Pacific	TREAT Asia	157341	wire transfe
East Asia/Pacific	TREAT Asia	49114	wire transfe
East Asia/Pacific	TREAT Asia	60000	wire transfe
East Asia/Pacific	TREAT Asia	72917	wire transfe
East Asia/Pacific	TREAT Asia	47176	wire transfe
East Asia/Pacific	TREAT Asia	47176	wire transfe
East Asia/Pacific	TREAT Asia	49050	wire transfe
East Asia/Pacific	TREAT Asia	48320	wire transfe
East Asia/Pacific	TREAT Asia	61650	wire transfe
East Asia/Pacific	TREAT Asia	49050	wire transfe
East Asia/Pacific	TREAT Asia	65400	wire transfe
East Asia/Pacific	TREAT Asia	48320	wire transfe
East Asia/Pacific	TREAT Asia	49050	wire transfe
East Asia/Pacific	TREAT Asia	79290	wire transfe
East Asia/Pacific	TREAT Asia	52000	wire transfe
East Asia/Pacific	TREAT Asia	6560	wire transfe
East Asia/Pacific	TREAT Asia	6480	wire transfe
East Asia/Pacific	TREAT Asia	37320	wire transfe
East Asia/Pacific	TREAT Asia	5001	wire transfe
East Asia/Pacific	TREAT Asia	5001	wire transfe
East Asia/Pacific	TREAT Asia	12501	wire transfe
East Asia/Pacific	TREAT Asia	47808	wire transfe
East Asia/Pacific	TREAT Asia	53577	wire transfe
East Asia/Pacific	TREAT Asia	10584	wire transfe
East Asia/Pacific	TREAT Asia	16918	wire transfe
East Asia/Pacific	TREAT Asia	58740	wire transfe
East Asia/Pacific	TREAT Asia	9990	wire transfe
East Asia/Pacific	TREAT Asia	10000	wire transfe
East Asia/Pacific	TREAT Asia	10000	wire transfe
East Asia/Pacific	TREAT Asia	10000	wire transfe
Europe	Social/Behavioral Research	15614	wire transfe
Europe	Basic Research	15626	wire transfe
Europe	Clinical Research	12000	wire transfe
Europe	Basic Research	10398	wire transfe
Europe	Basic Research	62501	wire transfe
Europe	Basic Research	57452	wire transfe
Europe	Basic Research	150000	wire transfe
Europe	MSM Initiative	9000	wire transfe
Europe	MSM Initiative	14980	wire transfe
Europe	TREAT Asia	15000	wire transfe
Russia/Newly Independent	MSM Initiative	14560	wire transfe
Russia/Newly Independent	MSM Initiative	10000	wire transfe
Russia/Newly Independent	MSM Initiative	15000	wire transfe
Russia/Newly Independent	MSM Initiative	30000	wire transfe
Russia/Newly Independent	MSM Initiative	15000	wire transfe
Russia/Newly Independent	MSM Initiative	30000	wire transfe
South America	MSM Initiative	9500	wire transfe
South America	MSM Initiative	10000	wire transfe
South America	MSM Initiative	13900	wire transfe
South America	MSM Initiative	15000	wire transfe
South America	MSM Initiative	12716	wire transfe
South America	MSM Initiative	15000	wire transfe
South America	MSM Initiative	14993	wire transfe
South America	MSM Initiative	7300	wire transfe
South America	MSM Initiative	15000	wire transfe
South America	MSM Initiative	15000	wire transfe
South America	MSM Initiative	15000	wire transfe
South Asia	TREAT Asia	16500	wire transfe
South Asia	TREAT Asia	11250	wire transfe
South Asia	TREAT Asia	11250	wire transfe
South Asia	TREAT Asia	14999	wire transfe
Sub-Saharan Africa	Social/Behavioral Research	57054	wire transfe
Sub-Saharan Africa	MSM Initiative	15000	wire transfe
Sub-Saharan Africa	MSM Initiative	10077	wire transfe
Sub-Saharan Africa	MSM Initiative	13800	wire transfe
Sub-Saharan Africa	MSM Initiative	15000	wire transfe
Sub-Saharan Africa	MSM Initiative	15000	wire transfe
Sub-Saharan Africa	MSM Initiative	15000	wire transfe
Sub-Saharan Africa	MSM Initiative	15000	wire transfe
Sub-Saharan Africa	MSM Initiative	15750	wire transfe

Field	Value	IRS element (for citing)
Total Number Of501c3 Orgs	131	TotalNumberOf501c3Orgs
Total Number Of Other Orgs	0	TotalNumberOfOtherOrgs

Form990 Schedule F Part IV Form990ScheduleFPartIV (3 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
Foreign Activities	Part I, Line 2	International organizations are recommended for funding based upon the results of community-based peer review and/or program staff assessment of proposal merit and organization capacity to undertake proposed projects that are CHARITABLE in purpose. Pre-award due-diligence for new international grantees includes review of organization documents and registrations to verify that the organization operates for a CHARITABLE purpose and that basic capacity for project oversight and governance has been established. All international grantees are required to report semi-annually on project progress and expenditures; continued reporting is required until such time as grant funds are expended in full. Reports are reviewed by administrative and program staff. Additional oversight is provided as necessary by means of ongoing, informal contact with sites regarding progress and technical issues and site visits where feasible. International research grant recipients submit an interim and a final progress reporting addition to expenditures reports due following the ends of the 2nd, 3rd and final quarters of the performance period.
foreign activities	Part I, Line 3, Column D	The Foundation for AIDS Research conducts many of its grant-making program services (see Part III of Form 990) in U.S. and foreign jurisdictions. In column D, the organization has reported the basic program these grants support; please refer to Part III for more information about these programs/initiatives.
Foreign Activities - Status of Grantees		The Foundation for Aids Research supports many non-U.S. organizations in the fight against AIDS and HIV-related diseases. For purposes of Schedule F, Part II, Line 2 - all 131 charities supported are presumed to be the equivalent of U.S. charities.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	X	MailSolicitations
Email Solicitations	X	EmailSolicitations
Phone Solicitations	X	PhoneSolicitations
Solicitation Of Non Govt Grants	X	SolicitationOfNonGovtGrants
Solicitation Of Govt Grants	X	SolicitationOfGovtGrants
Special Fundraising Events	X	SpecialFundraisingEvents
Agreement Ref Fundraising	true	AgreementRefFundraising

Fundraiser Activity Information FundraiserActivityInformation (7 entries)

Name Of IndividualNameOfIndividual	ActivityActivity	Fundraiser Control Of FundsFundraiserControlOfFunds	Gross ReceiptsGrossReceipts	Amount Retained By ContractorAmountRetainedByContractor	Net To OrganizationNetToOrganization
aab productions	Fundraising Event/Prod	false	9350226	322200	9028026
john mini consulting inc	direct mail	false	1574907	117500	1457407
livet reichard company inc	event production	false	3692476	102375	3590101
public interest communications	tele marketing	false	99905	59692	40213
sgr consulting	event production	false	417170	42000	375170
share group inc	tele marketing	false	5387	0	5387
telefund	tele marketing	false	153863	59921	93942

Field	Value	IRS element (for citing)
Total Gross Receipts	15293934	TotalGrossReceipts
Total Retained By Contractors	703688	TotalRetainedByContractors
Total Net To Organization	14590246	TotalNetToOrganization
Licensed States	AL	LicensedStates
Licensed States	AK	LicensedStates
Licensed States	AZ	LicensedStates
Licensed States	AR	LicensedStates
Licensed States	CA	LicensedStates
Licensed States	CO	LicensedStates
Licensed States	CT	LicensedStates
Licensed States	DC	LicensedStates
Licensed States	FL	LicensedStates
Licensed States	GA	LicensedStates
Licensed States	HI	LicensedStates
Licensed States	IL	LicensedStates
Licensed States	KS	LicensedStates
Licensed States	KY	LicensedStates
Licensed States	LA	LicensedStates
Licensed States	ME	LicensedStates
Licensed States	MD	LicensedStates
Licensed States	MA	LicensedStates
Licensed States	MI	LicensedStates
Licensed States	MN	LicensedStates
Licensed States	MS	LicensedStates
Licensed States	MO	LicensedStates
Licensed States	NH	LicensedStates
Licensed States	NJ	LicensedStates
Licensed States	NM	LicensedStates
Licensed States	NY	LicensedStates
Licensed States	NC	LicensedStates
Licensed States	ND	LicensedStates
Licensed States	OH	LicensedStates
Licensed States	OK	LicensedStates
Licensed States	OR	LicensedStates
Licensed States	PA	LicensedStates
Licensed States	RI	LicensedStates
Licensed States	SC	LicensedStates
Licensed States	TN	LicensedStates
Licensed States	TX	LicensedStates
Licensed States	UT	LicensedStates
Licensed States	VA	LicensedStates
Licensed States	WA	LicensedStates
Licensed States	WV	LicensedStates
Licensed States	WI	LicensedStates

Events Information EventsInformation

Field	Value	IRS element (for citing)
Name Of Event1	cannes	NameOfEvent1
Gross Receipts Event1	6046069	GrossReceiptsEvent1
Charitable Contributions Event1	2265572	CharitableContributionsEvent1
Gross Revenue Event1	3780497	GrossRevenueEvent1
Rent Facility Costs Event1	394093	RentFacilityCostsEvent1
Other Direct Expenses Event1	1549524	OtherDirectExpensesEvent1
Name Of Event2	dallas	NameOfEvent2
Gross Receipts Event2	3759396	GrossReceiptsEvent2
Charitable Contributions Event2	1084670	CharitableContributionsEvent2
Gross Revenue Event2	2674726	GrossRevenueEvent2
Rent Facility Costs Event2	37917	RentFacilityCostsEvent2
Other Direct Expenses Event2	2077865	OtherDirectExpensesEvent2
Total Number Of Other Events	18	TotalNumberOfOtherEvents
Gross Receipts Other Events	6310244	GrossReceiptsOtherEvents
Charitable Contrib Other Events	4488557	CharitableContribOtherEvents
Gross Revenue Other Events	1821687	GrossRevenueOtherEvents
Rent Facility Costs Other Events	66823	RentFacilityCostsOtherEvents
Other Direct Expenses Other Events	1860799	OtherDirectExpensesOtherEvents
Gross Receipts Total	16115709	GrossReceiptsTotal
Charitable Contributions Total	7838799	CharitableContributionsTotal
Gross Revenue Total Events	8276910	GrossRevenueTotalEvents
Rent Facility Costs Total Events	498833	RentFacilityCostsTotalEvents
Other Direct Expenses Total Events	5488188	OtherDirectExpensesTotalEvents
Direct Expense Summary Events	5987021	DirectExpenseSummaryEvents
Net Income Summary	2289889	NetIncomeSummary

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Records Maintained	true	RecordsMaintained

Recipient Table RecipientTable (36 entries)

Address Line1AddressUS/AddressLine1	CityAddressUS/City	StateAddressUS/State	ZIP CodeAddressUS/ZIPCode	EIN Of RecipientEINOfRecipient	IRC SectionIRCSection	Amount Of Cash GrantAmountOfCashGrant	Purpose Of GrantPurposeOfGrant
Dana Farber Cancer Institute
44 Binney St	Boston	MA	02115	042263040	501(c)(3)	123752	Basic Research
The University of Pennsylvania School of Medicine
3451 Walnut St	Philadelphia	PA	19104	231352685	501(c)(3)	15626	Basic Research
Aaron Diamond AIDS Research Center
455 First Avenue 7th Floor	New York	NY	10016	133540234	501(c)(3)	15626	Basic Research
University of Missouri-Columbia
310 Jesse Hall	Columbia	MO	65211	436003859	501(c)(3)	15626	Basic Research
University of Washington
1100 Fairview Avenue N D3-100	Seattle	WA	98109	916001537	501(c)(3)	15626	Basic Research
The J David Gladstone Institute
1650 Owen Street	San Francisco	CA	94158	237203666	501(c)(3)	32319	Basic Research
Yale University
47 College Street	New Haven	CT	06520	060649730	501(c)(3)	40680	Social/Behavioral
Univ of North Carolina at Chapel Hill
104 Airport Drive Suite 2200 CB 1	Chapel Hill	NC	27599	566001393	501(c)(3)	63483	Basic Research
University of Utah
75 S 2000 E Second Fl	Salt Lake City	UT	84112	187600525	501(c)(3)	62501	Basic Research
University of Texas at Austin
PO Box 7726	Austin	TX	78712	746000203	501(c)(3)	30000	Basic Research
The University of Michigan
3003 South State Street	Ann Arbor	MI	48109	386006309	501(c)(3)	30000	Basic Research
Washington University School of Medicine
660 S Euclid Ave	St Louis	MO	63110	143065361	501(c)(3)	30000	Basic Research
University of Utah
75 S 2000 E Second Fl	Salt Lake City	UT	84112	187600525	501(c)(3)	62501	Basic Research
Yale University School of Medicine
47 College Street	New Haven	CT	06520	060646973	501(c)(3)	62501	Basic Research
Virginia Commonwealth University
PO Box 980568	Richmond	VA	232980568	546001758	501(c)(3)	49957	Social/Behavioral
San Francisco Department of Health
1380 Howard Street 5th Fl	San Francisco	CA	94102	946000417	501(c)(3)	25606	Social/Behavioral
Weill Medical College of Cornell Univ
1300 York Avenue	New York	NY	10065	131623978	501(c)(3)	46872	Basic Research
UT Southwestern Medical Center
5323 Harry Hines Blvd	Dallas	TX	753909105	175600286	501(c)(3)	46872	Basic Research
NYU School of Medicine
550 First Avenue	New York	NY	10016	113556230	501(c)(3)	46872	Basic Research
University of California-Davis
One Shields Avenue	Davis	CA	95616	946036494	501(c)(3)	36456	Basic Research
California Institute of Technology
1200 East California Blvd	Pasadena	CA	91106	951643307	501(c)(3)	36456	PreClinical Research
University of Minnesota
200 Oak Street SE	Minneapolis	MN	554552070	416007513	501(c)(3)	36456	Basic Research
University of Florida
1600 SW Archer Rd ARB R1-252	Gainesville	FL	32610	592729133	501(c)(3)	70000	Basic Research
University of WashingtonFHCRC
1100 Fairview Avenue N D3-100	Seattle	WA	98109	916001537	501(c)(3)	70000	Basic Research
University of Texas Southwestern
5323 Harry Hines Blvd L4256	Dallas	TX	75390	175600286	501(c)(3)	70000	Basic Research
Albert Einstein College of Medicine
1300 Morris Park Avenue	Bronx	NY	10461	132937352	501(c)(3)	46667	Basic Research
San Francisco AIDS Foundation
995 Market Street Suite 200	San Francisco	CA	94103	942927405	501(c)(3)	5500	Research/Conference Support
The Regents of the University of California San Fr
333 California Street Suite 315	San Francisco	CA	94110	946036493	501(c)(3)	150000	Basic Research
Johns Hopkins University
733 N Broadway Suite 117 Broadwa	Baltimore	MD	21205	520595110	501(c)(3)	150000	Basic Research
Beckman Research Institue of City of Hope
1500 E Duarte Road	Duarte	CA	910103000	953432210	501(c)(3)	50000	Basic Research
NYU School of Medicine
550 First Avenue	New York	NY	10016	113556230	501(c)(3)	11000	Social/Behavioral
Montefiore Medical Center
111 E 210th St	Bronx	NY	10467	131740114	501(c)(3)	11000	Policy Research
University of California Los Angeles
11000 Kinross Avenue Ste 102	Los Angeles	CA	900951406	956006143	501(c)(3)	25000	Research/Conference Support
Global Forum on MSM and HIV
611 S Kingsley Drive	Los Angeles	CA	90005	953842506	501(c)(3)	10000	MSM Initiative
The Fenway Institute
1340 Boylston Street	Boston	MA	02115	425105640	501(c)(3)	10000	MSM Initiative
Beth Israel Medical Center
First Avenue at 18th Street	New York	NY	10003	135564934	501(c)(3)	115000	Policy Research

Field	Value	IRS element (for citing)
Total Nbr Of501 C3 And Govt Grants	36	TotalNbrOf501C3AndGovtGrants
Total Nbr Of Other Organizations	0	TotalNbrOfOtherOrganizations

Form990 Schedule I Part IV Form990ScheduleIPartIV

Field	Value	IRS element (for citing)
Identifier	Grants and Assistance	Identifier
Return Reference	Part I, Line 2	ReturnReference
Explanation	All U.S. 501(c)(3) grant and award recipients are required to report at least once on activities supported with amfAR funds; all U.S. research grant recipients (which include 501(c)(3) organizations and other nonprofit entities such as state universities) are required to submit an interim and a final progress report in addition to expenditure reports due following the ends of the 2nd, 3rd and final quarters of the performance periods. Reports are reviewed by grant administration and program staff prior to payment and/or closeout.	Explanation

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Compensation Committee	X	CompensationCommittee
Independent Consultant	X	IndependentConsultant
Written Employment Contract	X	WrittenEmploymentContract
Compensation Survey	X	CompensationSurvey
Board Or Committee Approval	X	BoardOrCommitteeApproval
Severance Payment	true	SeverancePayment
Supplemental Nonqual Retire Plan	true	SupplementalNonqualRetirePlan
Equity Based Comp Arrangement	false	EquityBasedCompArrangement
Comp Based On Revenue Of Filing Org	false	CompBasedOnRevenueOfFilingOrg
Comp Based On Revenue Related Orgs	false	CompBasedOnRevenueRelatedOrgs
Comp Based Net Earnings Filing Org	false	CompBasedNetEarningsFilingOrg
Comp Based Net Earnings Relate Orgs	false	CompBasedNetEarningsRelateOrgs
Any Non Fixed Payments	false	AnyNonFixedPayments
Initial Contract Exception	false	InitialContractException

Form990 Schedule J Part II Form990ScheduleJPartII (10 entries)

Base Compensation Filing OrgBaseCompensationFilingOrg	Comp Based On Related OrgsCompBasedOnRelatedOrgs	Bonus Filing OrgBonusFilingOrg	Bonus Related OrgsBonusRelatedOrgs	Other Compensation Filing OrgOtherCompensationFilingOrg	Other Compensation Related OrgsOtherCompensationRelatedOrgs	Deferred Comp Filing OrgDeferredCompFilingOrg	Deferred Comp Related OrgsDeferredCompRelatedOrgs	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg	Nontaxable Benefits Related OrgsNontaxableBenefitsRelatedOrgs	Total Compensation Filing OrgTotalCompensationFilingOrg	Total Compensation Related OrgsTotalCompensationRelatedOrgs	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrg	Comp Report Prior990 Related OrgsCompReportPrior990RelatedOrgs
Jerome J Radwin
0	0	0	0	300000	0	0	0	0	0	300000	0	0	0
Kevin Frost
294100	0	0	0	0	0	24650	0	7567	0	326317	0	0	0
John F Logan JD PhD
179424	0	0	0	0	0	12740	0	7568	0	199732	0	0	0
Rowena Johnston
138712	0	0	0	0	0	9842	0	7729	0	156283	0	0	0
Bradley Jensen
192220	0	0	0	0	0	10238	0	24291	0	226749	0	0	0
annette sohn
161626	0	0	0	0	0	8955	0	3475	0	174056	0	0	0
joshua lamont
146897	0	0	0	27500	0	0	0	7262	0	181659	0	0	0
Eric Muscatell
140535	0	0	0	0	0	10025	0	8213	0	158773	0	0	0
Jeff Smith
89330	0	0	0	30000	0	0	0	8122	0	127452	0	0	0
Andrew McInness
123398	0	0	0	0	0	8780	0	23435	0	155613	0	0	0

Form990 Schedule J Part III Form990ScheduleJPartIII

Field	Value	IRS element (for citing)
Identifier	Compensation	Identifier
Return Reference	Part I, Line 4	ReturnReference
Explanation	Chief Executive Officer, Kevin Frost, participated in a supplemental nonqualified retirement plan; however, he did not receive a distribution in 2009. Jerome J. Radwin received severance in calendar year 2009 totaling $300,000. Joshua Lamont, Vice President of Public Information, separated from service as of November 13, 2009. For purposes of the Form 990, Mr. Lamont is a current officer. He received a severance payment totaling $27,500 in 2009. This severance payment is reflected in Schedule J, Column (b)(iii). Jeffrey Smith, Director of the Treat Asia Program, separated from service as of August 31, 2009. For purposes of the Form 990, Mr. Smith is a former officer. He received a severance payment totaling $30,000 in 2009. This severance payment is reflected in Schedule J, Column (b)(iii).	Explanation

Schedule M IRS990ScheduleM

Field	Value	IRS element (for citing)
Works Of Art		WorksOfArt
Art Historical Treasures		ArtHistoricalTreasures
Art Fractional Interest		ArtFractionalInterest
Books And Publications		BooksAndPublications
Clothing And Household Goods		ClothingAndHouseholdGoods
Cars And Other Vehicles		CarsAndOtherVehicles
Boats And Planes		BoatsAndPlanes
Intellectual Property		IntellectualProperty

Securities Publicly Traded SecuritiesPubliclyTraded

Field	Value	IRS element (for citing)
Non Cash Checkbox	X	NonCashCheckbox
Number Of Contributions	5	NumberOfContributions
Noncash Contribs Rptd F990	5373	NoncashContribsRptdF990
Method Of Determining Revenues	sales price	MethodOfDeterminingRevenues

Field	Value	IRS element (for citing)
Securities Closely Held Stock		SecuritiesCloselyHeldStock
Securities Prtnrshp Trust Intrsts		SecuritiesPrtnrshpTrustIntrsts
Securities Miscellaneous		SecuritiesMiscellaneous
Qualified Contrib Hist Struct		QualifiedContribHistStruct
Qualified Contrib Other		QualifiedContribOther
Real Estate Residential		RealEstateResidential
Real Estate Commercial		RealEstateCommercial
Real Estate Other		RealEstateOther
Collectibles		Collectibles
Food Inventory		FoodInventory
Drugs And Medical Supplies		DrugsAndMedicalSupplies
Taxidermy		Taxidermy
Historical Artifacts		HistoricalArtifacts
Scientific Specimens		ScientificSpecimens
Archaeological Artifacts		ArchaeologicalArtifacts
Any Property That Must Be Held	false	AnyPropertyThatMustBeHeld
Review Process Unusual NC Gifts	false	ReviewProcessUnusualNCGifts
Third Parties Used	false	ThirdPartiesUsed

Schedule O IRS990ScheduleO

General Explanation GeneralExplanation (9 entries)

IdentifierIdentifier	Return ReferenceReturnReference	ExplanationExplanation
Program Service Accomplishments	Part III, Line 4a-4d	Line 4a RESEARCH amfAR supports research projects that explore novel approaches to scientifically sound but untested hypotheses in all areas of research on HIV/AIDS, funding goal-oriented studies that often lack the preliminary data required for support from traditional grant-makers. The Foundation plays a vital role in HIV/AIDS research, identifying critical gaps in knowledge and providing essential seed money that enables grantees and fellows to test the merits of new concepts or technologies that subsequently can be validated through large-scale studies, such as those funded by the National Institutes of Health. amfAR fellowships allow talented young investigators to conduct original investigations under the guidance of experienced scientists, helping to ensure the long-term vitality of AIDS research. New Grants and Fellowships Grants and fellowships are awarded through a rigorous process of peer review by a team of independent HIV/AIDS experts drawn largely from the volunteer scientists on amfAR's Scientific Advisory Committee. Guided by its scientific advisors and with the approval of its board of trustees, amfAR pursues a strategic research plan that focuses on the treatment, prevention, and cure of HIV/AIDS. In 2010, amfAR awarded 17 new grants and fellowships totaling $2,518,674. Three researchers received Mathilde Krim Fellowships in Basic Biomedical Research, an initiative that provides funding for exceptional young researchers who are new to the field of HIV/AIDS research. The initiative has already achieved spectacular results, including numerous published studies in major scientific journals. The 2010 Krim Fellows-each of whom received $125,000-are conducting studies of viral resistance to antiretroviral drugs, the ways in which HIV binds to cell proteins, and how HIV overcomes the body's natural defenses. Among the 2010 fellows is Thomas Gramberg, Ph.D., of the NYU School of Medicine, whose research aims to understand how HIV is able to overcome the natural antiviral defenses of cells. He is characterizing proteins in cells that would normally have antiviral effects but are overcome by two proteins made by HIV, and pinpointing which part of the replication cycle is targeted. These insights may provide new targets for antiretroviral drug development. Two researchers who were among the inaugural group of Krim Fellows in January 2008 received Phase II funding totaling $142,675 to continue their research. Rogier Sanders, Ph.D., of the Academic Medical Center, University of Amsterdam, has been working to modify the envelope protein surrounding HIV with the goal of improving potential vaccines based on this protein. In phase II, he will characterize the antibody responses induced by these "evolved" envelope proteins. amfAR also announced its first ever awards for gene therapy research- three grants and three fellowships totaling $735,000. The funded projects represent a broad range of gene therapy interventions aimed at blocking HIV infection and eradicating the virus. Keith Jerome, M.D., Ph.D., is using homing endonucleases-a type of molecular scissors-to lethally cut up HIV's DNA. This method of attack can target HIV even when it is inactive-unlike anti-HIV drugs, which target the virus only when it reproduces-and thus may be a means of eradicating HIV from the body completely. Placing the search for a cure for HIV/AIDS at the center of its research efforts, the Foundation launched the amfAR Research Consortium on HIV Eradication (ARCHE) in May 2010. The first round of funding, totaling $1.2 million, went to four collaborative teams of researchers working in three areas considered central to HIV eradication: the search for a sterilizing cure to eliminate HIV from the body; the search for a functional cure to suppress the virus without treatment; and the characterization of viral reservoirs, which present an obstacle to a cure. Among these researchers is Robert Siliciano, M.D., Ph.D., of Johns Hopkins University, collaborating with Janice Clements, Ph.D. They are studying drugs that have already been approved to treat other conditions, with the aim of testing whether these agents might reduce or even eradicate the virus in the body or the number of cells harboring latent HIV. If successful, these studies could point the way to strategies that could shorten the development time of drugs to cure HIV. In 2010, amfAR also worked with the New York HIV Research Centers Consortium to fund two inaugural awards totaling $65,999 for a new research initiative aimed at shaping health policy and treatment programs across the state. Dr. Carolyn Chu of Montefiore Medical Center, is studying health service delivery and treatment outcomes of HIV patients at primary care clinics in the Bronx; and Dr. Susan Abramowitz of NYU School of Medicine, is evaluating interventions for HIV-infected adolescents. Published Research Research studies make the greatest impact on the AIDS field and on the broader scientific community when they are published in scientific journals. In the past year, at least 34 scientific publications resulted from amfAR-funded research. These covered current and past targeted areas of research interest. Keys to a New Anti-HIV Compound Our ability to control the growth of HIV and block its attack on immune cells is based on having a large repertoire of drugs belonging to different drug classes, each of which slows the life cycle of the virus at different stages of growth. Dr. Bruno Marchand, who received a Krim Fellowship from amfAR in 2009, reports in the Journal of Biological Chemistry on the mechanism of action of a new type of reverse transcriptase (RT) inhibitor, known as EFdA, which has the potential to become a new anti-HIV drug. EFdA is closely related to the RT inhibitors that became the first FDA-approved HIV medications, but it has greater potency and a different mechanism of action. Studying how this new inhibitor works may aid in the development of a new and more effective weapon in the anti-HIV arsenal. Reducing HIV Growth to Zero Could intensifying anti-HIV treatment slow virus growth rates even further than current highly active antiretroviral therapy (HAART) regimens, or even eradicate the virus? amfAR-funded researcher Dr. Sarah Palmer of the Swedish Institute for Infectious Disease Control, with colleagues from other institutions, explored this question in an article in Nature Medicine. The researchers studied patients whose virus levels were already well controlled on standard HAART but who had extremely low but measurable amounts of virus in their blood. The scientists added another drug, raltegravir, to their regimen, and studied patients' DNA for signs of accumulating virus that was stopped by the additional drug. Their findings suggested that although most patients on HAART do not show signs of viral growth, one-third of the patients studied had ongoing viral growth, which was impeded by the addition of raltegravir to their treatment regimen. HIV, HAART, and the Kidneys Mild kidney disease is seen in up to one-third of HIV-positive individuals, but the prevalence of more significant chronic kidney disease is expected to increase as the HIV-positive population ages. Writing in AIDS, amfAR grantee Dr. Steven Deeks and his colleagues at the University of California, San Francisco, reported on the relationships between HIV, HAART, and the risk of developing kidney disease. They found that HAART slowed the loss of kidney function, but that loss of function continued nonetheless and accelerated in patients on HAART who experienced intermittent rises in viral load. This study was part of an ongoing trial known as SCOPE-Study of the Consequences of the Protease Inhibitor Era-that examines the impact of anti-HIV drugs as people with HIV live longer. New Targeted RFP amfAR issued a request for proposals (RFP) in September 2010 for studies exploring the mechanisms whereby HIV persists; the chronic nature of viral reservoirs and latency; and barriers to the eradication of HIV, with the potential goal of ultimately eliminating HIV infection. Think Tanks and Conferences Following the announcement of first-round funding for amfAR's cure consortium, ARCHE, researchers from the four teams met at amfAR's offices in June 2010 to discuss their research and explore ideas for future collaborations among the consortium members.
Program Service Accomplishments	Part III, Line 4a-4d	Line 4b TREAT ASIA amfAR's TREAT Asia program (Therapeutics Research, Education, and AIDS Training in Asia) involves a network of hospitals, clinics, and research institutions working with civil society to ensure the safe and effective delivery of HIV/AIDS treatments across Asia and the Pacific. The TREAT Asia Network encompasses 23 adult and 20 pediatric sites throughout the region, which collaborate on a variety of projects. Eight papers based on the network's research were published in U.S. and international scientific journals in 2010. TREAT Asia HIV Observational Database (TAHOD) TREAT Asia pioneered the region's first adult observational database for HIV/AIDS, which now includes anonymous data collected from more than 6,400 patients at 23 clinical sites in 13 countries. The information gathered and analyzed through the database informs the development of more effective research and treatment programs, and helps define treatment standards specific to HIV/AIDS in Asia. TREAT Asia Pediatric Network Representing more than 5,000 HIV-positive children in Asia, TREAT Asia's Pediatric Network includes 20 sites in seven countries; these sites share information and best practices in an effort to improve the quality of pediatric care in the region. The TREAT Asia Pediatric HIV Observational Database (TApHOD) was modeled on the adult TAHOD program, and includes data from approximately 3,600 pediatric patients at 16 clinical sites in Cambodia, India, Indonesia, Malaysia, Thailand, and Vietnam. TREAT Asia Studies to Evaluate Resistance (TASER) TREAT Asia has worked for the past five years with organizations in the Netherlands to build capacity to monitor the emergence and spread of HIV drug resistance in Asia and Africa. As more countries expand access to antiretroviral therapy, monitoring resistance to first-line treatments is essential, particularly in countries where access to second-line drugs is limited. The TREAT Asia Studies to Evaluate Resistance (TASER) made significant progress during 2010. For its monitoring study, which monitors the emergence of drug-resistant HIV in infected patients, nine clinical centers have now enrolled more than 1,500 patients in Hong Kong, Indonesia, Malaysia, the Philippines, and Thailand. For its surveillance study, which evaluates the spread of drug-resistant virus among newly infected patients, two clinical centers in Thailand and one in Hong Kong enrolled a total of 87 patients in 2010. As part of TASER's work, TREAT Asia also runs a laboratory quality assurance program to ensure the accuracy and consistency of the HIV genetic analysis required to determine if HIV has become resistant to drugs. International AIDS Database TREAT Asia manages the Asia-Pacific section of the International Epidemiologic Databases to Evaluate AIDS (IeDEA), a global collaboration established by the U.S. National Institute of Allergy and Infectious Diseases. To support IeDEA, TREAT Asia is contributing anonymous data from approximately 13,400 patients at 61 clinical centers at 55 institutions in 15 countries within Asia and Australia. Exploring Links Between HIV and Cancer Among HIV-positive men who have sex with men (MSM), the risk of anal cancer is twice the level of those who are HIV negative, but little research has been done on this issue in Asia. With funding from IeDEA, in December 2009 TREAT Asia began the second phase of an innovative research study exploring the links between HIV and anal cancer and looking at cancer biomarkers in an attempt to better identify MSM with pre-cancerous anal lesions. Building Research Capacity TREAT Asia has implemented a research education program to help network members strengthen their skills in conducting clinical research and to boost the overall quality of care in the region. The program, supported by the Australian Agency for International Development, provides training for researchers and clinicians in Cambodia, China, Indonesia, the Philippines, Papua New Guinea, and Vietnam. In late 2009 and early 2010, TREAT Asia organized several workshops and training sessions including a training on good clinical research practice, held in Jakarta, Indonesia, in October 2009; a two-part training in clinical epidemiology for pediatric specialists in Vietnam, held in November 2009 and February 2010 in Ho Chi Minh City; and two English-language scientific writing workshops, held in China in January and June 2010. The Purple Sky Network TREAT Asia serves as regional coordinating secretariat for the Purple Sky Network, which works in the Greater Mekong Sub-region to address the rise of HIV among MSM. The network, which brings together more than 80 organizations in Cambodia, Laos, Myanmar, Thailand, Vietnam, and China's Yunnan and Guangxi provinces, created a formal governance structure and established a set of priorities for its ongoing work. Advocacy efforts that reduce stigma and discrimination against MSM and transgender people will cut across the diverse social and political settings within the region. Building Community Treatment Literacy and Promoting Advocacy for Treatment Access Communicating treatment information about a disease as complex as HIV/AIDS can be daunting, but patients' lives depend on it. TREAT Asia works closely with local and regional groups to support treatment literacy activities in China, where it helps support the award-winning AIDS Care China program; and in Cambodia, where it provides assistance to the Cambodian Community of Positive Women. TREAT Asia also began a new partnership with UNAIDS, the Asia-Pacific Network of People Living with HIV/AIDS, the International Treatment Preparedness Coalition, and the Mdecins Sans Frontires Access Campaign. Through the newly formed Asia Treatment Working Group, TREAT Asia will be part of a platform for promoting treatment access and higher quality HIV healthcare within the region. AIDS Research Information for Asia In 2010, TREAT Asia continued to publish lay-language articles about topical new research in the fields of prevention, treatment, and basic science. The goal of these articles is to explain HIV/AIDS research advances for people living with HIV/AIDS and their families, communities, and caregivers across Asia. The articles appear in the TREAT Asia Report and on TREAT Asia's website, www.treatasia.org, where they are also available as PDFs in a variety of Asian languages including Bahasa Indonesia, Burmese, Chinese, Khmer, and Thai. XVIII International AIDS Conference TREAT Asia was well represented at the XVIII International AIDS Conference, held in July 2010 in Vienna, Austria, where several network members and partners presented their research findings. In addition, TREAT Asia was a scientific co-sponsor of the 2nd International Workshop on HIV Pediatrics, which preceded the conference. 13th Bangkok Symposium on HIV Medicine amfAR continued its support of this annual regional symposium, which was held in January 2010 and was organized by HIV-NAT, a TREAT Asia network site.
Program Service Accomplishments	Part III, Line 4a-4d	Line 4c EDUCATION AND INFORMATION amfAR seeks to translate and disseminate information on important AIDS-related research, treatment, prevention, and policy issues for diverse audiences and to stimulate broad awareness of the need for better treatment and prevention methods. amfAR also publishes a wide range of educational materials, maintains an informative website, and engages respected public figures, HIV/AIDS scientists, and policy makers in communicating the need for continued research to develop new methods of prevention, treatment, and, ultimately, a cure for AIDS. Educational Materials amfAR produces a range of periodicals in both print and electronic formats, including its newsletter Innovations, published twice a year and distributed to more than 40,000 people; the TREAT Asia Report, published and distributed three times a year to more than 4,000 readers in the international health community; and a monthly e-mail newsletter distributed to more than 40,000 people. The Foundation's website features news, interviews, and original articles covering science, policy, the global epidemic, and amfAR programs and activities. amfAR also creates and distributes program reports, press releases, and updates on major HIV/AIDS issues, and conducts public service advertising campaigns that have been instrumental in educating policy makers, healthcare professionals, people with HIV/AIDS, and the general public. Media Outreach amfAR continued to work closely with the media to raise the profile of HIV/AIDS, both domestically and internationally, and to help ensure the accuracy of AIDS press coverage. Articles and reports involving amfAR-many of which included interviews with amfAR spokespeople-were carried in numerous media outlets, including the Wall Street Journal, The Financial Times, the New York Times, the Washington Post, Nature, the Associated Press, Reuters, and Bloomberg News. On December 1, 2009-World AIDS Day-CNN's American Morning featured a profile of amfAR Chairman Kenneth Cole, focusing on his AIDS activism and longtime involvement with amfAR. Also on World AIDS Day, amfAR was a co-sponsor of the global Light for Rights campaign, which focused attention on the need to protect the human rights of those living with HIV. amfAR's public awareness efforts are greatly enhanced by the committed support of public figures who lend their voices and donate their time, talents, and resources to help sustain the Foundation's mission. amfAR is profoundly grateful for the continuing steadfast support of Founding International Chairman Elizabeth Taylor and Global Fundraising Chairman Sharon Stone. In 2010, these supporters included amfAR Ambassadors Cheyenne Jackson, Milla Jovovich, Liza Minnelli, and Michelle Yeoh, as well as Alan Cumming, Whoopi Goldberg, Kylie Minogue, Vanessa Redgrave, Maggie Rizer, Martin Sheen, Meryl Streep, and Stanley Tucci.
Program Service Accomplishments	Part III, Line 4a-4d	THE MSM INITIATIVE amfAR's MSM Initiative was launched in 2007 to respond to the alarmingly high rates of HIV among MSM, a group that in low- and middle-income countries is on average 19 times more likely to be infected than the general population. Stigma, discrimination, and legal prohibitions have fueled the spread of the epidemic among MSM, most of whom do not have access to HIV prevention, treatment, and care services. The MSM Initiative aims to reduce the spread and impact of HIV infection among MSM in resource-limited countries by providing support to grassroots groups through its community awards program. The program also works to raise awareness of HIV among MSM and to advocate increased funding for MSM-targeted services. Community Awards In 2010, amfAR awarded more than $660,000 to 41 groups in Africa, Asia and the Pacific, the Caribbean, Eastern Europe and Central Asia, and Latin America for a wide range of projects addressing HIV prevention, outreach, education, advocacy, testing, research, and capacity building. Africa amfAR awarded funding to nine groups in Africa: Alternatives-Cameroun (Cameroon); Association de lutte contre le sida (Morocco); Espace Confiance (Cte d'Ivoire); Gay and Lesbian Coalition of Kenya in partnership with Ishtar MSM (Kenya); PEMA Kenya (Kenya); South African Network of Religious Leaders Living with or Personally Affected by HIV & AIDS (South Africa); Stop AIDS in Liberia (Liberia); Friends of RAINKA (Zambia); and one organization that requested anonymity (Uganda). Association de lutte contre le sida (Morocco) Association de lutte contre le sida is using its community award in Marrakesh to establish an MSM-friendly drop-in health center, a safe space where MSM can receive social support, medical care, and HIV and syphilis testing and counseling. The group is also creating pamphlets and other materials about HIV and sexually transmitted infections (STIs) for MSM, distributing condoms and lubricant, and sponsoring information sessions in the community. Asia-Pacific Eight organizations in Asia and the Pacific received community awards: Action for AIDS (Singapore); Bandhu Social Welfare Society (Bangladesh); Chengdu Tongle Counseling and Service Center (China); Red Ribbon Initiative (Pakistan); Mplus+ (Thailand); STD/HIV/AIDS Prevention Center (Vietnam); Yayasan Gaya Celebes (Indonesia); and one organization that requested anonymity (India). Chengdu Tongle Counseling and Service Center (China) This group is providing capacity-building support to 18 key MSM/HIV grassroots organizations across China by hiring legal professionals to advise groups about their rights and assist them in fighting human rights violations. In addition to developing a legal manual, the group is cultivating a national network of groups addressing MSM and HIV in order to facilitate technical assistance projects in the future. Caribbean Seven grassroots organizations in the Caribbean received amfAR funding: Centro de Orientacin e Investigacin Integral (Dominican Republic); Fondation Esther Boucicault Stanislas (Haiti); Jamaica Forum for Lesbians, All-Sexuals, and Gays (Jamaica); MSM No Political Agenda (Trinidad and Tobago); SEROvie (Haiti); Society Against Sexual Orientation Discrimination-Guyana (Guyana); and United Belize Advocacy Movement (Belize). SEROvie (Haiti) SEROvie is using its MSM Initiative community award to continue the work it began using a previous award from amfAR to provide outreach and social services for MSM living with and affected by HIV. In addition to building communication skills to promote healthy behaviors, the project provides psychosocial support and referrals to services. SEROvie has also provided basic support for its clients affected by the January 2010 earthquake. Eastern Europe and Central Asia Seven groups in Eastern Europe and Central Asia received community awards from amfAR's MSM Initiative, which was one of the first programs to support HIV services for MSM in the region. Awardees include CSO Equal Opportunities (Tajikistan); New Life Organization (Russia); Nikolaev Regional Public Youth Movement-Penitentiary Initiative (Ukraine); Public Fund Gender Vector (Kazakhstan); Safe Pulse of Youth (Serbia); The Siberian Alternative Center (Russia); and We for Civil Equality (Armenia). Nikolaev Regional Youth Movement - Penitentiary Initiative (Ukraine) The Penitentiary Initiative, a second-year MSM grantee, is using its community award to scale up a program providing HIV outreach to MSM in prison settings, where they are often considered outcasts. Through the program, the group conducts training to reduce stigma and discrimination by prison staff and other prisoners, and provides psychosocial support and HIV prevention for MSM prisoners. Latin America amfAR made community awards to 10 MSM groups in Latin America: Akuaipa Waimakat - Asociacin Para La Divulgacin, Promocin y Defensa de los Derechos Humanos e Indgenas (Colombia); Asociacin ALFIL (Equador); Articulao e Movimento para Travestis e Transexuals de Pernambuco (Brazil); Asociacin Civil De Desarrollo Social Y Promocion Cultural Adesproc Libertad GLBT (Bolivia); Asociacin Un Nuevo Camino ASUNCAMI (Bolivia); Asociacin Solidaria Para Impulsar el Desarrollo Humano (El Salvador); Colectivo SerGay de Aguascalientes A.C. (Mexico); Grupo Gnesis Panam Positivo (Panama); Vallarta Enfrenta el Sida A.C. (Mexico); and one organization that requested anonymity (Brazil). Colectivo SerGay de Aguascalientes A.C. (Mexico) This organization works to reduce the spread of HIV among MSM by engaging peer educators (young men and transgender people) to conduct outreach in parks and bars; distribute condoms, lubricant, and safe sex information; offer peer counseling; and promote LGBT-friendly HIV testing and support services. The group also employs counselors at an LGBT community center to offer support to clients. Publications As part of its efforts to raise awareness among governments, donors, and international nongovernmental organizations of the spread of HIV among MSM and to advocate effective strategies for addressing it, amfAR publishes reports on HIV and MSM. Just prior to the XVIII International AIDS Conference in July 2010, amfAR published a collection of case studies from 10 MSM grantees, Lessons from the Front Lines: Effective Community-Led Responses to HIV and AIDS Among MSM and Transgender Populations. PUBLIC POLICY Informed by thorough research and analysis, amfAR is a highly respected advocate of rational and compassionate AIDS-related public policy. The Foundation is engaged in efforts to secure necessary increases in funding for HIV/AIDS research; implement the new National HIV/AIDS Strategy; expand access to care and treatment; and protect the civil rights of all people affected by HIV/AIDS. Harm Reduction As one of the earliest supporters of comprehensive harm reduction programs for injection drug users (IDUs), including syringe exchange, amfAR has played a leading role in advocating the implementation of these lifesaving programs. In December 2009, the Foundation celebrated a major victory on this front when Congress lifted the ban on federal funding for syringe exchange programs (SEPs). amfAR also funds the only annual national survey of U.S. SEPs, which is traditionally published in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report (MMWR). Under contract with the New York State Department of Health's AIDS Institute, amfAR continued to administer the distribution of harm reduction supplies to the 19 authorized SEPs statewide, which have served more than 143,000 registered participants. Shaping the Domestic Response to HIV/AIDS amfAR has long advocated the implementation of a comprehensive national HIV/AIDS strategy to address the ongoing epidemic in the U.S., where more than one million people are living with the virus. In late 2009, amfAR co-sponsored two consultations aimed at developing recommendations for the strategy: one on research and the other on prevention. The Foundation was also a co-author of a paper titled "Moving Beyond the Status Quo," which it provided to the White House Office of National AIDS Policy (ONAP). These efforts culminated in the launch of a National HIV/AIDS Strategy in July 2010, which reflected many of the recommendations set forth by the Foundation and its fellow AIDS advocates. Also in July, Vice President and Director of Public Policy Chris Collins participated in a panel discussion on the strategy at the XVIII International AIDS Conference.
Program Service Accomplishments	Part III, Line 4a-4d	Among those living with HIV in the U.S. are a growing number of young people, many of whom have no idea they are infected. In September 2010, public health experts, researchers, clinicians, and activists gathered for an amfAR-sponsored Congressional briefing on HIV and youth, at which they discussed the complex biological and psychosocial factors driving the spread of HIV among young people, and the multifaceted approaches required to prevent and treat the virus within this diverse population. At the briefing, the Foundation released an issue brief, Youth and HIV/AIDS in the United States: Challenges and Opportunities for Prevention. Global Health In 2010, public policy staff worked with fellow AIDS advocates to argue for increased funding for global HIV/AIDS initiatives, including the President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria. In addition to meeting with key administration officials and members of Congress, amfAR released a series of publications making the case for boosting global AIDS funding. In December 2009, the Foundation partnered with the IDSA Center for Global Health Policy on an issue brief, Smart Investments in AIDS and Global Health: Building on What Works. amfAR also prepared several issue briefs on global health in conjunction with the XVIII International AIDS Conference: The Shifting Global Health Landscape: Implications for HIV/AIDS and Vulnerable Populations, HIV/AIDS Investments: Building Blocks for Global Health?, and MSM and the Global HIV/AIDS Epidemic: Assessing PEPFAR and Looking Forward. In March 2010, the public policy office helped organize a Capitol Hill hearing on the importance of increased HIV/AIDS global health funding for the House Foreign Affairs Subcommittee on Africa and Global Health. MSM amfAR's policy office works closely with the MSM Initiative to advocate expanded access to HIV prevention and treatment services for MSM worldwide, and to fight the stigma and discrimination that make MSM more vulnerable to HIV infection and inhibit equal access to care. In addition to publishing its issue brief on MSM and PEPFAR (as described above), the Foundation joined other advocates in opposing a proposed anti-homosexuality bill in Uganda and in calling for a greater focus on MSM in domestic HIV/AIDS prevention programs. AIDS Research Funding Advocating increased funding for lifesaving HIV/AIDS research is another of amfAR's policy priorities. In March 2010, amfAR and the Treatment Action Group released an issue brief, A Sound Investment: The Multiplier Effect of AIDS Research, outlining the ways in which HIV/AIDS research has benefitted other areas of medical research and explaining the importance of sustained funding for the National Institutes of Health. Pre-Exposure Prophylaxis Pre-exposure prophylaxis (PrEP)-which involves giving antiretroviral therapy to HIV-negative people at high risk of becoming infected-holds great promise as a potential prevention intervention. In December 2009, amfAR co-sponsored a think tank on the Intermittent PrEP (iPrEP) research agenda, at which research and policy leaders reviewed current research in this area and suggested priorities for moving forward. HIV and Immigration amfAR's longtime efforts to repeal a ban on travel and immigration to the U.S. by HIV-positive foreigners were rewarded in October 2009, when President Obama announced the end of the ban, which took effect in January 2010.
Policies	Form 990, Part VI, Section B	Line 11 - The Form 990 was prepared by a nationally renowned accounting firm in conjunction with the organization's financial department. A copy of the draft Form 990 was circulated to the full Board of Trustees for discussion and comment. Each Board Member was provided ample opportunity to comment on the information contained in the 990 prior to its filing with the Internal Revenue Service. Line 12 - Each officer, director, trustee and key employee of amFar ("foundation") is required to annually disclose any conflicts of interest that arise by virtue of employment, board service, or position with the foundation. The foundation monitors compliance with its conflict of interest policy through an annual questionnaire/disclosure statement that is distributed to these individuals. Potential conflicts are investigated immediately. Line 15 - amfar ("foundation") undertakes a thorough process to ensure that the executive compensation it pays to its top management official and all of its officers and key employees of organization is reasonable given the market in which the foundation operates. An independent consultant prepares salary ranges and recommendations. Staff compensation is determined by established ranges and established annual salary increase guidelines as determined by CEO and CFO. CEO compensation is submitted for endorsement to the Board's compensation committee.
Disclosure	Form 990, Part VI, Section C	LIne 19 - amfar makes its Form 990 available to the public by retaining a copy at its place of business and on its website, www.amfar.org. The Form 990 is likewise published on the internet at www.guidestar.org. The Foundation's financial statements are made available in its annual report and on its website. The Foundation's governing documents and conflict of interest policy are not ordinarily made available to the public, but, if requested, will be provided at management's discretion.
Functional Expenses	Part IX, Lines 1 & 3	The Foundation for AIDS Research reports its grants net of grant returns or recoveries. Periodically, grants remitted to charitable organizations are returned to AMFAR for a variety of reason. On Schedules F & I, grants are reported irrespective of whether they were ultimately returned to AMFAR since categorizing the "returned" amounts would be time consuming. Therefore, amounts reported on Part IX, Line 1 will not tie to total grants on Schedule I; amounts reported on Part IX, Line 3 will not tie to total grants on Schedule F.
Fundraising Narrative	Schedule G, Part I	The Foundation for AIDS Research actually paid out $483,987 in fundraising expenses for the year ending September 30, 2010. This amount is reported on Part IX, Line 11(e). For purposes of Schedule G, the Foundation is reporting all amounts paid to the consultants listed on Part I, regardless of whether such amounts were pure fundraising expenses or event production costs. On Schedule G, the total amount paid to the organizations listed is $703,688. Of that $703,688, only $483,987 was paid for fundraising services, the remaining $219,701 was paid for event production services.